Department of Dermatology

Psoriasis - Occurrence and Reality: Disease of the Psoriasis Group (2017) Leupolz S, Sticherling M Conference contribution Psoriasis vulgaris as Manifestation of Immune Reconstitution in Patients with Hepatitis C under Treatment with Ledipasvir/Sofosbuvir (2017) Heppt F, Sticherling M Conference contribution Lungs Ailment - other Comorbidity of the Psoriasis? (2017) Moreira A, Sticherling M Conference contribution PASI <= 2 corresponds to PASI 90, irrespective of baseline severity: A post-hoc analysis of the PRIME-study (2017) Reich K, Sieder C, Bachhuber T, Melzer N, Sticherling M Conference contribution Look-alikes with opposite consequences: Cutaneous Botryomycosis presenting as cutaneous metastases in a patient with a history of metastatic lung cancer (2017) Bosch-Voskens C, Woerl P, Kiesewetter F, Schliep S Conference contribution Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibition (2017) Heppt M, Heinzerling L, Kaehler K, Forschner A, Kirchberger M, Loquai C, Meissner M, et al. Conference contribution Psoriasis in children: a single-centre analysis (2017) Heppt F, Raap J, Sticherling M Conference contribution RNA-transfection of gamma/delta T cells with a chimeric antigen receptor or an alpha/ss T-cell receptor: a safer alternative to genetically engineered alpha/ss T cells for the immunotherapy of melanoma (2017) Harrer D, Simon B, Fujii SI, Kanako S, Uslu U, Schuler G, Gerer KF, et al. Conference contribution FRA-1 TRANSCRIPTION FACTOR EXPRESSION IN MACROPHAGES FOSTER INFLAMMATION DURING RHEUMATOID ARTHRITIS DEVELOPMENT (2017) Hannemann N, Schnelzer A, Jordan J, Eberhardt M, Schleicher U, Hueber A, Reid S, et al. Conference contribution Eosinophilic count as a biomarker for prognosis of melanoma patients (2017) Moreira A, Heinzerling L Conference contribution